Neurobiology of animal models of attention-deficit hyperactivity disorder

被引:98
作者
Russell, Vivienne Ann [1 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, ZA-7925 Observatory, South Africa
基金
英国医学研究理事会;
关键词
norepinephrine; dopamine; attention; hyperactivity; SHR; thyroid hormone;
D O I
10.1016/j.jneumeth.2006.12.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) is a heterogeneous, highly heritable, disorder resulting from complex gene-gene and gene-environment interactions. The defining symptoms of hyperactivity, impulsivity and impaired sustained attention are not unique to ADHD. It is therefore not surprising that animals with distinctly different neural defects model the behavioural characteristics of the disorder. Consistent with ADHD being a developmental disorder, animal models are either genetic (spontaneously hypertensive rats (SHR), dopamine transporter (DAT) knock-out mice, SNAP-25 mutant mice, mice expressing a mutant thyroid receptor) or have suffered an insult to the central nervous system during the early stages of development (anoxia, 6-hydroxydopamine). It appears that neural transmission is impaired by either direct disruption of dopaminergic transmission or a more general impairment of neurotransmission that gives rise to compensatory changes in monoaminergic systems that are not sufficient to completely normalize neural function. In general, results obtained with animal studies suggest that dopamine neurons are functionally impaired. However, evidence obtained from some animal models suggests that the noradrenergic and serotonergic neurotransmitter systems may be the target of drugs that ameliorate ADHD symptoms. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 198
页数:14
相关论文
共 155 条
[1]   Catecholamine modulation of prefrontal cortical cognitive function [J].
Arnsten, AFT .
TRENDS IN COGNITIVE SCIENCES, 1998, 2 (11) :436-447
[2]  
Arnsten AFT, 2006, J CLIN PSYCHIAT, V67, P7
[3]   Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder [J].
Arnsten, Amy F. T. ;
Dudley, Anne G. .
BEHAVIORAL AND BRAIN FUNCTIONS, 2005, 1 (1)
[4]  
ASTONJONES G, 1994, J NEUROSCI, V14, P4467
[5]   Neuroenergetics and the kinetic design of excitatory synapses [J].
Attwell, D ;
Gibb, A .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (11) :841-849
[6]   Metabolic alterations in the prefrontal and cingulate cortices are related to behavioral deficits in a rodent model of attention-deficit hyperactivity disorder [J].
Barbelivien, A ;
Ruotsalainen, S ;
Sirviö, J .
CEREBRAL CORTEX, 2001, 11 (11) :1056-1063
[7]   The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice [J].
Barr, AM ;
Lehmann-Masten, V ;
Paulus, M ;
Gainetdinov, RR ;
Caron, MG ;
Geyer, MA .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (02) :221-228
[8]   Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder [J].
Barr, CL ;
Feng, Y ;
Wigg, K ;
Bloom, S ;
Roberts, W ;
Malone, M ;
Schachar, R ;
Tannock, R ;
Kennedy, JL .
MOLECULAR PSYCHIATRY, 2000, 5 (04) :405-409
[9]   Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder [J].
Berger, DF ;
Sagvolden, T .
BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) :73-82
[10]   Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's [J].
Berridge, KC ;
Aldridge, JW ;
Houchard, KR ;
Zhuang, XX .
BMC BIOLOGY, 2005, 3 (1)